Technology
Health
Medical

Aethlon Medical

$0.945
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0151 (-1.57%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AEMD and other stocks, options, ETFs, and crypto commission-free!

About

Aethlon Medical, Inc. Common Stock, also called Aethlon Medical, is a therapeutic technology company, which focuses on addressing global health and biodefense needs. Read More It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.

Employees
6
Headquarters
San Diego, California
Founded
1998
Market Cap
17.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
163.54K
High Today
$0.986
Low Today
$0.9469
Open Price
$0.98
Volume
110.24K
52 Week High
$1.74
52 Week Low
$0.8216

Collections

Technology
Health
Medical
Cancer Prevention
US
North America

News

MarketBeatMar 18

Stock Price, News, & Analysis for Aethlon Medical

News coverage about AEMD stock has trended positive on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aethlon Medical earned a news impact score of 2.2 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a new...

5
Simply Wall StMar 14

What Type Of Shareholder Owns Aethlon Medical, Inc.’s (NASDAQ:AEMD)?

The big shareholder groups in Aethlon Medical, Inc. (NASDAQ:AEMD) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. I quite like to see at least a little bit of insider ownership. As Charlie Munger said ‘Show me the incentive and I will show you the outcome.’ Aethlon Medical is not a large company by global standards. It has a market capitalization of US$19m, which means it wouldn’t have the attention...

85
PR NewswireMar 7

Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs

SAN DIEGO, March 7, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device company focused on addressing critical unmet needs in global health, announces the appointment of Lisa M. Boswell, to the position of Director, Quality Systems and Regulatory Affairs. Ms. Boswell has over 15 years of experience in Quality Control, Quality Assurance and Regulatory Affairs in both the biopharmaceutical and medical device industries, most recently as Director, Quality Assurance and Regul...

75

Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Jun 7, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.